Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model

Mesenchymal stem cells (MSCs) secrete bioactive factors that exert diverse responses in vivo . In the present study, we explored mechanism how MSCs may lead to higher functional recovery in the animal stroke model. Bone marrow-derived MSCs were transplanted into the brain parenchyma 3 days after ind...

Full description

Saved in:
Bibliographic Details
Published inExperimental & molecular medicine Vol. 40; no. 4; pp. 387 - 397
Main Authors Yoo, Seung-Wan, Kim, Sung-Soo, Lee, Soo-Yeol, Lee, Hey-Sun, Kim, Hyun-Soo, Lee, Young-Don, Suh-Kim, Haeyoung
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 31.08.2008
Springer Nature B.V
Korean Society of Medical Biochemistry and Molecular Biology
생화학분자생물학회
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Mesenchymal stem cells (MSCs) secrete bioactive factors that exert diverse responses in vivo . In the present study, we explored mechanism how MSCs may lead to higher functional recovery in the animal stroke model. Bone marrow-derived MSCs were transplanted into the brain parenchyma 3 days after induction of stroke by occluding middle cerebral artery for 2 h. Stoke induced proliferation of resident neural stem cells in subventricular zone. However, most of new born cells underwent cell death and had a limited impact on functional recovery after stroke. Transplantation of MSCs enhanced proliferation of endogenous neural stem cells while suppressing the cell death of newly generated cells. Thereby, newborn cells migrated toward ischemic territory and differentiated in ischemic boundaries into doublecortin + neuroblasts at higher rates in animals with MSCs compared to control group. The present study indicates that therapeutic effects of MSCs are at least partly ascribed to dual functions of MSCs by enhancing endogenous neurogenesis and protecting newborn cells from deleterious environment. The results reinforce the prospects of clinical application using MSCs in the treatment of neurological disorders.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
These authors contributed equally to this work.
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0620920080400040387
G704-000088.2008.40.4.005
ISSN:1226-3613
2092-6413
DOI:10.3858/emm.2008.40.4.387